Quest Diagnostics Receives First FDA Clearance for H1N1 MDx Test

As a result of the 510(k) clearance, Quest's Simplexa Influenza A H1N1 test will be the only one that can be marketed after June 23 when the public emergency stemming from the virus is lifted.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories